跳至主要内容
临床试验/NCT02089178
NCT02089178终止不适用

Comparison of the Effect of Total Intravenous Anesthesia and Inhalation Anesthesia on Cancer Cell Cytotoxicity, Micrometastasis and Recurrence of Tumor in Patients Undergoing Breast Tumor Resection

Yonsei University1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2014年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
48
试验地点
1
主要终点
number of NK cell

研究概览

简要总结

The purpose of this study is to compare the effect of total intravenous anesthesia and inhalation anesthesia on cancer cell cytotoxicity, micrometastasis and recurrence of tumor in patients undergoing breast tumor resection. Using propofol-remifentanil in total intravenous anesthesia group and sevoflurane -remifentanil in inhalation anesthesia group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • patient between 20 and 65 of age with ASA physical status Ⅰ-Ⅲ
  • breast cancer patients with no sign of local invasion (adjacent organs) and distant metastasis revealed by imaging studies
  • surgery performed by the same surgical team

排除标准

  • ASA physical status Ⅳ
  • hepatic and renal impairment
  • diabetes or other endocrine disorders
  • body mass index > 35 kg/m2
  • immune disorders or immunosuppressive therapy
  • steroid treatment in the last 6 months
  • inflammation

研究组 & 干预措施

intravenous

Experimental

the total intravenous anesthesia group

干预措施: intravenous anesthesia (Procedure)

intravenous

Experimental

the total intravenous anesthesia group

干预措施: propofol-remifentanil (Drug)

inhalation

Active Comparator

the inhalation anesthesia group

干预措施: inhalation anesthesia (Procedure)

inhalation

Active Comparator

the inhalation anesthesia group

干预措施: sevoflurane-remifentanil (Drug)

结局指标

主要结局

number of NK cell

时间窗: at 24 hour after surgery.

comparison of the effect of total intravenous anesthesia and inhalation anesthesia on cancer cell cytotoxicity

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验